KNTE logo

Kinnate Biopharma (KNTE) Operating Profit

Annual Operating Profit

-$119.01 M
-$487.00 K-0.41%

December 1, 2023


Summary


Performance

KNTE Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherKNTEprofitabilitymetrics:

Quarterly Operating Profit

-$19.10 M
+$12.01 M+38.60%

December 1, 2023


Summary


Performance

KNTE Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherKNTEprofitabilitymetrics:

TTM Operating Profit

-$119.01 M
+$13.58 M+10.24%

December 1, 2023


Summary


Performance

KNTE TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherKNTEprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

KNTE Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-0.4%+38.6%+10.2%
3 y3 years-230.6%+38.6%+10.2%
5 y5 years-1459.7%+38.6%+10.2%

KNTE Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+32.1%at lowat high+81.4%+32.1%+11.6%
5 y5-year+890.7%at low+379.4%+81.4%+2886.4%+11.6%
alltimeall time+1459.7%at low+379.4%+81.4%+2886.4%+11.6%

Kinnate Biopharma Operating Profit History

DateAnnualQuarterlyTTM
Dec 2023
-$119.01 M(+0.4%)
-$19.10 M(-38.6%)
-$119.01 M(-10.2%)
Sep 2023
-
-$31.12 M(-8.8%)
-$132.59 M(-0.2%)
Jun 2023
-
-$34.13 M(-1.5%)
-$132.84 M(+5.3%)
Mar 2023
-
-$34.65 M(+6.0%)
-$126.11 M(+6.4%)
Dec 2022
-$118.52 M(+31.5%)
-$32.68 M(+4.2%)
-$118.52 M(+5.7%)
Sep 2022
-
-$31.37 M(+14.5%)
-$112.10 M(+6.2%)
Jun 2022
-
-$27.41 M(+1.3%)
-$105.53 M(+5.9%)
Mar 2022
-
-$27.06 M(+3.0%)
-$99.69 M(+10.6%)
Dec 2021
-$90.11 M
-$26.26 M(+5.9%)
-$90.11 M(+16.2%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$24.80 M(+15.0%)
-$77.57 M(+22.6%)
Jun 2021
-
-$21.57 M(+23.4%)
-$63.27 M(+28.3%)
Mar 2021
-
-$17.48 M(+27.4%)
-$49.33 M(+37.0%)
Dec 2020
-$36.00 M(+199.7%)
-$13.72 M(+30.6%)
-$36.00 M(+37.1%)
Sep 2020
-
-$10.50 M(+37.7%)
-$26.27 M(+66.6%)
Jun 2020
-
-$7.63 M(+83.6%)
-$15.76 M(+93.7%)
Mar 2020
-
-$4.15 M(+4.2%)
-$8.14 M(+104.2%)
Dec 2019
-$12.01 M(+57.4%)
-$3.98 M
-$3.98 M
Dec 2018
-$7.63 M
-
-

FAQ

  • What is Kinnate Biopharma annual operating income?
  • What is the all time high annual operating profit for Kinnate Biopharma?
  • What is Kinnate Biopharma annual operating profit year-on-year change?
  • What is Kinnate Biopharma quarterly operating income?
  • What is the all time high quarterly operating profit for Kinnate Biopharma?
  • What is Kinnate Biopharma quarterly operating profit year-on-year change?
  • What is Kinnate Biopharma TTM operating income?
  • What is the all time high TTM operating profit for Kinnate Biopharma?
  • What is Kinnate Biopharma TTM operating profit year-on-year change?

What is Kinnate Biopharma annual operating income?

The current annual operating profit of KNTE is -$119.01 M

What is the all time high annual operating profit for Kinnate Biopharma?

Kinnate Biopharma all-time high annual operating income is -$7.63 M

What is Kinnate Biopharma annual operating profit year-on-year change?

Over the past year, KNTE annual operating income has changed by -$487.00 K (-0.41%)

What is Kinnate Biopharma quarterly operating income?

The current quarterly operating profit of KNTE is -$19.10 M

What is the all time high quarterly operating profit for Kinnate Biopharma?

Kinnate Biopharma all-time high quarterly operating income is -$3.98 M

What is Kinnate Biopharma quarterly operating profit year-on-year change?

Over the past year, KNTE quarterly operating income has changed by +$12.01 M (+38.60%)

What is Kinnate Biopharma TTM operating income?

The current TTM operating profit of KNTE is -$119.01 M

What is the all time high TTM operating profit for Kinnate Biopharma?

Kinnate Biopharma all-time high TTM operating income is -$3.98 M

What is Kinnate Biopharma TTM operating profit year-on-year change?

Over the past year, KNTE TTM operating income has changed by +$13.58 M (+10.24%)